Skip to main content
Premium Trial:

Request an Annual Quote

Celera Genomics Narrows Loss

Click herefor an updated version of this story.


NEW YORK, July 23 - The Celera Genomics Group of Applera this morning reported a net loss of $19.4 million for its fourth quarter ending June 30, compared to a net loss of $28.8 million for the same period last year.


The Rockville, Md.-based company had revenues of $21.5 million for the quarter, compared to $28.1 million for the year-ago quarter.


The company had R&D expenses of $28.5 million, compared to $36.7 million for the fourth quarter of 2002.

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.